• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Pneumococcal vaccine uptake among Medicare Beneficiaries aged ≥65 years following the shared clinical decision-making recommendation for 13-valent pneumococcal conjugate vaccine in 2019
CONCLUSIONS: PCV13 use decreased among immunocompetent and immunocompromised persons alike, despite continued routine PCV13 recommendation for the latter group.PMID:37474408 | DOI:10.1016/j.vaccine.2023.07.034
Source: Vaccine - July 20, 2023 Category: Allergy & Immunology Authors: Jeffrey Vietri Reiko Sato Ahuva Averin Derek Weycker Mahesh Kumar Sapna Prasad Erica Chilson Source Type: research

Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S
CONCLUSION: Pneumococcal vaccination remains low and most adults with underlying conditions are unvaccinated. Insights into factors associated with vaccination, including regional variability, can help to increase pneumococcal vaccination.PMID:35803847 | DOI:10.1016/j.vaccine.2022.06.068
Source: Vaccine - July 8, 2022 Category: Allergy & Immunology Authors: Anna Ostropolets Linda Shoener Dunham Kelly D Johnson Junqing Liu Source Type: research

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination
Vaccine. 2022 Mar 12:S0264-410X(22)00269-9. doi: 10.1016/j.vaccine.2022.03.005. Online ahead of print.ABSTRACTWe evaluated compliance to the ACIP pneumococcal vaccination recommendations issued in 2014 for adults aged ≥ 65 years and in 2012 for adults with high-risk (HR) conditions. The MarketScan® Commercial and Medicare Supplemental databases (January 2007-June 2019) were used to identify the cohorts of interest. Analyses for adults aged ≥ 65 years were adjusted to account for missing vaccination history. Two HR cohorts were identified. The HR1 cohort included patients with immunocompromising conditions, functional ...
Source: Vaccine - March 16, 2022 Category: Allergy & Immunology Authors: Antonia Morga Tomomi Kimura Qi Feng Nigel Rozario Jason Schwartz Source Type: research

Medicare Advantage-pharmacy partnership improves influenza and pneumococcal vaccination rates
CONCLUSIONS: A health plan-enabled, pharmacist-led intervention was effective in increasing the number of older adults receiving pneumococcal vaccination and individuals receiving influenza vaccination.PMID:34668671 | DOI:10.37765/ajmc.2021.88760
Source: The American Journal of Managed Care - October 20, 2021 Category: Health Management Authors: Richard L Sheer David P Nau Nicholas Dorich Annette D Boyer Matthew Pickering Patrick J Campbell Margaret K Pasquale Source Type: research

Pages: 1  2